A dramatic drop in HIV testing, fueled by a severe funding crisis, has placed Nepal’s progress against the HIV/AIDS epidemic in immediate jeopardy, experts warned today at a media interaction program to mark World AIDS Day 2025.
While the country has achieved a significant, long-term decline in new HIV infections (down 89% since 2000) and AIDS-related deaths (down 76% since 2010), recent budget shortfalls are now reversing years of investment and success.
Data Reveals Alarming 34% Drop in HIV Testing
Data from the National Centre for AIDS and STD Control (NCASC) reveals an alarming trend in the first half of 2025. HIV testing fell by 34% compared to the same period in 2024, decreasing from 325,514 to 214,722 tests.
This sharp decline in testing has led to a proportional drop in new case detection. Experts warn that reduced testing makes it impossible to identify new infections, allowing the deadly disease to spread undetected. They caution that a person can remain asymptomatic for seven to ten years while still transmitting the virus. Studies indicate that one in every five HIV-infected people in Nepal is currently unaware of their status.
A Crisis of Funding and Suspended Aid
The core of the crisis is a lack of financial resources, with limited budgets and a significant withdrawal of support from international development partners.
- Domestic Funding: Accounts for only 36% of the total budget, which is just sufficient to purchase antiretroviral medicines and testing kits.
- Aid Suspended: Major aid agencies, including USAID, have suspended funding, and the budget from the Global Fund was reportedly not released on time this year.
These cuts have resulted in the indefinite halt of critical prevention programs. Hundreds of high-risk individuals—including female sex workers, gay men, and people taking injectable drugs—have been deprived of pre-exposure prophylaxis (PrEP) since January. Furthermore, awareness campaigns and community testing drives targeting these key vulnerable populations have been stalled.
Decades of Progress at Risk: Treatment Enrollment vs. Future Goals
Despite the funding setbacks, Nepal has made undeniable achievements in patient care:
- Treatment Coverage: 26,372 people, or 77% of the estimated 34,337 people living with HIV in 2024, are enrolled in free antiretroviral therapy (ART).
- Mother-to-Child Transmission: Cases among children under 14 years have dropped dramatically, with 37 new diagnoses in 2024, down 86% from 260 in 2010.
Speaking at the event, Dr. Sarvesh Sharma, Director of the NCASC, acknowledged the progress but stressed the immediate danger. “While we are moving in the right direction, we cannot be complacent,” Dr. Sharma said. “Sustained commitment, proper funding, and regular follow-up are essential if we want to end AIDS as a public health threat in Nepal.”
Nepal aims to meet the global 95–95–95 strategy (95% knowing their status, 95% on treatment, 95% virally suppressed) to end the AIDS epidemic by 2030, a target that now appears increasingly difficult without urgent budgetary and strategic interventions.